Prospettive Sociali e Sanitarie

Magali Reyes, Jan Buitelaar, Paz Toren, Ilse Augustyns, and Marielle Eerdekens
A Randomized, Double-Blind, Placebo-Controlled Study of Risperidone Maintenance Treatment in Children and
Adolescents With Disruptive Behavior Disorders 402-410
Robert Rosenheck, Douglas Leslie, Richard Keefe, Joseph McEvoy, Marvin Swartz, Diana Perkins, Scott Stroup, John
K. Hsiao, Jeffrey Lieberman, and CATIE Study Investigators Group
Barriers to Employment for People With Schizophrenia 411-417.
Christopher R. Bowie, Abraham Reichenberg, Thomas L. Patterson, Robert K. Heaton, and Philip D. Harvey
Determinants of Real-World Functional Performance in Schizophrenia Subjects: Correlations With Cognition,
Functional Capacity, and Symptoms 418-425
Richard S.E. Keefe, Margaret Poe, Trina M. Walker, Joseph W. Kang, and Philip D. Harvey
The Schizophrenia Cognition Rating Scale: An Interview-Based Assessment and Its Relationship to Cognition, Real-
World Functioning, and Functional Capacity 426-432
Steven J. Siegel, Farzin Irani, Colleen M. Brensinger, Christian G. Kohler, Warren B. Bilker, J. Daniel Ragland,
Stephen J. Kanes, Ruben C. Gur, and Raquel E. Gur
Prognostic Variables at Intake and Long-Term Level of Function in Schizophrenia
433-441
Frank Schneider, Ruben C. Gur, Kathrin Koch, Volker Backes, Katrin Amunts, N. Jon Shah, Warren Bilker, Raquel E.
Gur, and Ute Habel
Impairment in the Specificity of Emotion Processing in Schizophrenia 442-447
Mark J. Sergi, Yuri Rassovsky, Keith H. Nuechterlein, and Michael F. Green
Social Perception as a Mediator of the Influence of Early Visual Processing on Functional Status in Schizophrenia 448-
454
Toshiaki Onitsuka, Margaret A. Niznikiewicz, Kevin M. Spencer, Melissa Frumin, Noriomi Kuroki, Lisa C. Lucia,
Martha E. Shenton, and Robert W. McCarley
Functional and Structural Deficits in Brain Regions Subserving Face Perception in Schizophrenia 455-462
Jessica Andrews, Lei Wang, John G. Csernansky, Mokhtar H. Gado, and Deanna M. Barch
Abnormalities of Thalamic Activation and Cognition in Schizophrenia 463-469
Deborah J. Walder, Larry J. Seidman, Nicole Cullen, Jessica Su, Ming T. Tsuang, and Jill M. Goldstein
Sex Differences in Language Dysfunction in Schizophrenia 470-477
Colm McDonald, Nicolette Marshall, Pak C. Sham, Edward T. Bullmore, Katja Schulze, Ben Chapple, Elvira Bramon,
Francesca Filbey, Seema Quraishi, Muriel Walshe, and Robin M. Murray
Regional Brain Morphometry in Patients With Schizophrenia or Bipolar Disorder and Their Unaffected Relatives 478-
487
Juan Francisco Artaloytia, Celso Arango, Adrienne Lahti, Javier Sanz, Ana Pascual, Pedro Cubero, David Prieto, and
Tomás Palomo
Negative Signs and Symptoms Secondary to Antipsychotics: A Double-Blind, Randomized Trial of a Single Dose of
Placebo, Haloperidol, and Risperidone in Healthy Volunteers 488-493
Rajesh Gopalakrishnan, K.S. Jacob, Anju Kuruvilla, B. Vasantharaj, and Jacob K. John
Sildenafil in the Treatment of Antipsychotic-Induced Erectile Dysfunction: A Randomized, Double-Blind, Placebo-
Controlled, Flexible-Dose, Two-Way Crossover Trial 494-499
Laura B. Dunn, Barton W. Palmer, Monique Keehan, Dilip V. Jeste, and Paul S. Appelbaum
Assessment of Therapeutic Misconception in Older Schizophrenia Patients With a Brief Instrument 500-506
Henrik Berg Rasmussen, Sally Timm, August G. Wang, Karen Søeby, Henrik Lublin, Mogens Fenger, Ralf
Hemmingsen, and Thomas Werge
Association Between the CCR5 32-bp Deletion Allele and Late Onset of Schizophrenia 507-511
Anna Sorkin, Daphna Weinshall, Ilan Modai, and Avi Peled